BRAF and colorectal neoplasm: These analyses demonstrated that a MMR gene variant present in an MSI-H colorectal tumour has ~7–9-fold chance of being disease-causing, and if also wild-type BRAF the likelihood of being disease-causing increases to 12 to13-fold.